Increased fracture risk and osteoporosis not associated with vitamin D levels in Malaysian patients with inflammatory bowel disease

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 6, 2013, Pages 2415-2421

  Hilmi, Ida ^a   Sunderesvaran, K ^a   Ananda, Vijay ^a   Sarji, S A ^a   Arumugam, Kulenthran ^a   Goh, K L ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; PREDNISOLONE;

ADULT; ANKLE FRACTURE; ARTICLE; BONE DENSITY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENTERITIS; FEMALE; FEMUR FRACTURE; FOOT FRACTURE; FRACTURE; FRAGILITY FRACTURE; HIGH RISK POPULATION; HIP; HUMAN; INCIDENCE; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALAYSIA; MALE; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPINE; TIBIA FRACTURE; ULCERATIVE COLITIS; VITAMIN BLOOD LEVEL; WRIST FRACTURE;

ADULT; AGED; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; FRACTURES, BONE; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALAYSIA; MALE; MIDDLE AGED; OSTEOPOROSIS; PROSPECTIVE STUDIES; RISK; VITAMIN D;

EID: 84878485289     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1147     Document Type: Article

References (37)

1. Reinshagen M. Osteoporosis in inflammatory bowel disease. J Crohns Colitis. 2008;2(3):202-207.
2. Agrawal M, Arora S, Li J, et al. Bone, Inflammation, and inflammatory bowel disease. Curr Osteoporos Rep. 2011;9(4):251-257.
3. Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut. 1997;40(2):228-233. (Pubitemid 27093099)
4. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study. Scand J Gastroenterol. 2004;39(2):145-153. (Pubitemid 38253626)
5. Adachi JD, Rostom A. Metabolic bone disease in adults with inflammatory bowel disease. Inflamm Bowel Dis. 1999;5(3):200-211.
6. Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut. 1997;40(3):313-319. (Pubitemid 27145642)
7. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med. 2000;133(10):795-799.
8. Abitbol V, Roux C, Chaussade S, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology. 1995;108(2):417-422.
9. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37(2):192-199. (Pubitemid 34102257)
10. Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med. 2000;247(1):63-70. (Pubitemid 30073165)
11. Ardizzone S, Cassinotti A, Bevilacqua M, Clerici M, Porro GB. Vitamin D and inflammatory bowel disease. Vitam Horm. 2011;86:367-377.
12. Ardizzone S, Cassinotti A, Trabattoni D, et al. Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study. Int J Immunopathol Pharmacol. 2009;22(1):63-71.
13. Lim WC, Hanauer SB, Li YC. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2(7):308-315. (Pubitemid 41102862)
14. Hilmi I, Tan YM, Goh KL. Crohn's disease in adults: observations in a multiracial Asian population. World J Gastroenterol. 2006;12(9):1435-1438.
15. Ouyang Q, Tandon R, Goh KL, Ooi CJ, Ogata H, Fiocchi C. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol. 2005;21(4):408-413. (Pubitemid 40961165)
16. Thia KT, Loftus EV Jr., Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103(12):3167-3182.
17. Khadgawat R, Makharia GK, Puri K. Evaluation of bone mineral density among patients with inflammatory bowel disease in a tertiary care setting in India. Indian J Gastroenterol. 2008;27(3):103-106.
18. Tanaka I, Oshima H. [Glucocorticoid-induced osteoporosis and bone mineral densitometry]. Clin Calcium. 2004;14(12):77-82.
19. Cravo M, Guerreiro CS, dos Santos PM, et al. Risk factors for metabolic bone disease in Crohn's disease patients. Inflamm Bowel Dis. 2010;16(12):2117-2124.
20. de Jong DJ, Corstens FH, Mannaerts L, van Rossum LG, Naber AH. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease? Am J Gastroenterol. 2002;97(8):2011-2015.
21. Habtezion A, Silverberg MS, Parkes R, Mikolainis S, Steinhart AH. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis. 2002;8(2):87-92. (Pubitemid 34213505)
22. Pappa HM, Gordon CM, Saslowsky TM, et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics. 2006;118(5):1950-1961. (Pubitemid 46393676)
23. Bours PH, Wielders JP, Vermeijden JR, van de Wiel A. Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease. Osteoporos Int. 2011;22(11):2857-2867.
24. Rahman SA, Chee WS, Yassin Z, Chan SP. Vitamin D status among postmenopausal Malaysian women. Asia Pac J Clin Nutr. 2004;13(3):255-260. (Pubitemid 39329881)
25. Lim SK, Kung AW, Sompongse S, Soontrapa S, Tsai KS. Vitamin D inadequacy in postmenopausal women in Eastern Asia. Curr Med Res Opin. 2008;24(1):99-106. (Pubitemid 351160243)
26. Al-Saleh Y, Al-Daghri NM, Alkharfy KM, et al. Normal circulating PTH in Saudi healthy individuals with hypovitaminosis D. Horm Metab Res. 2013;45(1):43-46.
27. Bernstein CN, Bector S, Leslie WD. Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease. Am J Gastroenterol. 2003;98(11):2468-2473. (Pubitemid 37448758)
28. Noble CL, McCullough J, Ho W, et al. Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2008;27(7):588-596. (Pubitemid 351316781)
29. Selected bibliography of inflammatory bowel disease. Gastroenterology. 1966;51(5):949-951.
30. Cauley JA, Lacroix AZ, Wu L, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med. 2008;149(4):242-250.
31. Brinker MR, O'Connor DP, Monla YT, Earthman TP. Metabolic and endocrine abnormalities in patients with nonunions. J Orthop Trauma. 2007;21(8):557-570. (Pubitemid 47367964)
32. Leslie WD, Miller N, Rogala L, Bernstein CN. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastroenterol. 2008;103(6):1451-1459. (Pubitemid 351813899)
33. Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res. 2003;18(2):343-351. (Pubitemid 36125927)
34. Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. Fracture-associated hospitalizations in patients with inflammatory bowel disease. Dig Dis Sci. 2011;56(1):176-182.
35. Wagnon JH, Leiman DA, Ayers GD, Schwartz DA. Survey of gastroenterologists' awareness and implementation of AGA guidelines on osteoporosis in inflammatory bowel disease patients: are the guidelines being used and what are the barriers to their use? Inflamm Bowel Dis. 2009;15(7):1082-1089.
36. Henderson S, Hoffman N, Prince R. A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease. Am J Gastroenterol. 2006;101(1):119-123. (Pubitemid 43381718)
37. Abitbol V, Briot K, Roux C, et al. Adouble-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5(10):1184-1189. (Pubitemid 47496232)